Functioning neuroendocrine tumor of pancreas

Advocacy intelligence hub — real-time data for patient organizations

View full disease page →Search clinical trials →
Download CSV

At a Glance

Live from database

Regulatory Watchboard

4 events
Dec 2021Lutetium 177Lu-Edotreotide Versus Best Standard of Care in Well-differentiated Aggressive Grade-2 and Grade-3 GastroEnteroPancreatic NeuroEndocrine Tumors (GEP-NETs) - COMPOSE

ITM Solucin GmbH — PHASE3

TrialACTIVE NOT RECRUITING
Oct 2018Testing Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid Tumors

National Cancer Institute (NCI) — PHASE3

TrialACTIVE NOT RECRUITING
Feb 2017Efficacy and Safety of 177Lu-edotreotide PRRT in GEP-NET Patients

ITM Solucin GmbH — PHASE3

TrialACTIVE NOT RECRUITING
Oct 2000Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders

Mayo Clinic

TrialRECRUITING

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

0

Total programs

No financial assistance programs currently listed for Functioning neuroendocrine tumor of pancreas.
Check the disease page for updates →

Clinical Trial Landscape

3 active trials
2Phase 3
1Unknown
3Total recruiting
Search clinical trials for Functioning neuroendocrine tumor of pancreas

Recent News & Research

No recent news articles indexed yet for Functioning neuroendocrine tumor of pancreas.
Search PubMed for Functioning neuroendocrine tumor of pancreas

Browse all Functioning neuroendocrine tumor of pancreas news →

Specialist Network

Top 6 by expertise

View all Functioning neuroendocrine tumor of pancreas specialists →

Quick Actions